-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Castle Biosciences Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q2 2024.
- Castle Biosciences Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$1.03M, a 6563% decline year-over-year.
- Castle Biosciences Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$918K, a 1155% decline year-over-year.
- Castle Biosciences Inc annual Income Tax Expense (Benefit) for 2023 was $101K.
- Castle Biosciences Inc annual Income Tax Expense (Benefit) for 2022 was -$1.77M, a 20152% decline from 2021.
- Castle Biosciences Inc annual Income Tax Expense (Benefit) for 2021 was -$8.72K, a 110% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)